FDA approves first over-the-counter anti-overdose Narcan spray

The U.S. Food and Drug Administration announced Wednesday that it had approved Narcan for over-the-counter, nonprescription use.

The nasal spray becomes the first naloxone medication to be approved for these uses.

Naloxone, when used in the right timeframe, can rapidly reverse an opioid overdose and is widely considered the standard treatment for opioid overdose.